… Carbapenem-resistant Acinetobacter baumannii (CRAB) cause significant life-threating
hospital-acquired infections… list for research and development of new antibiotics, CRAB has been …

… for treatment of carbapenem-resistant Acinetobacter baumannii in… gram-negative infections:
potential new options facing multiple … New treatment options against carbapenem-resistant …

This review critically appraises the published microbiologic and clinical data on the treatment
of patients with carbapenem‐resistant Acinetobacter baumannii infections. Despite being …

… Carbapenem-resistant Acinetobacter baumannii (CRAB) has … requiring urgent new antibiotic
treatment options. Cefiderocol, … designed for the treatment of carbapenem-resistant Gram-…

… of ABC pneumonia [9], together with the encouraging data from the real-world clinical use
of cefiderocol [10,11], opens a new scenario for CRAB infections treatment. In this narrative …

… therapy for patients with a carbapenem-resistant Gram-negative pathogens, mortality was
higher in patients with A. baumannii infections treated … of a new era in CRAB infections with …

… a therapeutic option for carbapenem-resistant Acinetobacter baumannii (CRAB) infections,
but … (CRAB) as one of the species of critical importance for research and development of new …

… widespread attention to the treatment and control of CRAB. However, limited therapeutic
options, as well as the long study period and task difficulty involved in new drug development, …

… A promising new therapeutic option for CRAB is the combination of sulbactam with
durlobactam (SD), a new member of the diazabicyclooctane class of β-lactamase inhibitors, with …

… Ten critically ill patients with either bacteremia or ventilator-associated pneumonia caused
by carbapenem-resistant Acinetobacter baumannii, Stenotrophomonas maltophilia, or New …